ARTICLE
25 January 2022

Update On CMS Vaccine Mandate Monitoring And Enforcement

TS
Taft Stettinius & Hollister

Contributor

Established in 1885, Taft is a nationally recognized law firm serving individuals and businesses worldwide, in both mature and emerging industries.
As an update to our Jan. 13, 2022 law bulletin, the Centers for Medicare and Medicaid Services (CMS) is now proceeding with monitoring and enforcement of the CMS Vaccine Interim Final Rule (IFR) in all states.
United States Coronavirus (COVID-19)
To print this article, all you need is to be registered or login on Mondaq.com.

As an update to our Jan. 13, 2022 law bulletin, the Centers for Medicare and Medicaid Services (CMS) is now proceeding with monitoring and enforcement of the CMS Vaccine Interim Final Rule (IFR) in all states. 

The U.S. Supreme Court order on January 13 led to a series of regulatory announcements and lower court action. CMS first issued guidance explaining the 24 states impacted by the U.S. Supreme Court order must meet the Phase 1 compliance deadline under the CMS Vaccine IFR by Feb. 14, 2022. At that point, the only state that hadn't had an enforcement date announced was Texas, given an injunction was still in place pursuant to a District Court order. Last week the Texas case was dismissed. Accordingly, CMS is now also proceeding with monitoring and enforcement in Texas. The Phase 1 deadline for Texas is Feb. 22, 2022. 

CMS continues to update its Frequently Asked Questions on the CMS IFR, available on the CMS site  here.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More